Clinical Trials Browser

Phase 1 × INDUSTRY × Vomiting × Clear all

Vomiting

NCT01596426 2024-07-26

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Phase 1 Withdrawn

Vomiting

NCT01596400 2024-06-17

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Phase 1 Completed

19 enrolled

Vomiting

NCT04430842 2023-01-18

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Phase 1 Completed

15 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Sleepiness, Mesothelioma, Malignant, Anorexia, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Headache, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Seizures, Speech Disorders, Stomach Neoplasms, Thymoma, Tongue Neoplasms, Urologic Neoplasms, Vomiting, Colorectal Neoplasms, Cholangiocarcinoma

NCT00334646 2017-11-17

Cyclophosphamide Drug Interaction Study In Cancer Patients

Phase 1 Terminated

25 enrolled

Nausea, Vomiting

NCT00440128 2017-08-04

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Phase 1 Completed

12 enrolled

Nausea, Vomiting

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Phase 1 Completed

50 enrolled

Nausea, Neoplasms, Vomiting

Clinical Trials

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Cyclophosphamide Drug Interaction Study In Cancer Patients

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers